News

All current DZIF news can be found here.

A digitally colourised scanning electron microscopic (SEM) image depicting a single, red-coloured T cell infected by numerous, spheroid shaped, mustard-coloured HIV particles, which can be seen attached to the cell's surface membrane.

Longevity of HIV-neutralising antibodies explored

Despite decades of research, there is still no vaccine that protects against HIV infection. It is currently assumed, however, that such a vaccine can only be effective if it also produces so-called

A lab technician pipettes a sample into a sequencing device.

When (new) drugs don’t work: Mozambique faces alarming multidrug-resistant tuberculosis epidemic

With one of the highest tuberculosis (TB) incidences (368 cases/100,000 population) in the African region, Mozambique is particularly affected by the TB epidemic. Drug-resistant TB is also a major

The DZIF Executive Board including its new member. Back row from right to left: Prof. Dirk Busch, Prof. Hans-Georg Kräusslich, Prof. Thomas Pietschmann; front row from right to left: Prof. Andreas Peschel and Prof. Maura Dandri. Front left: Dr Timo Jäger, Managing Director of the DZIF.

Thomas Pietschmann elected to the Executive Board of the DZIF

Professor Thomas Pietschmann, Scientific Co-Director of the Helmholtz Centre for Infection Research (HZI), Professor of Experimental Virology at Hannover Medical School (MHH) and virologist at

A lab technician at a sterile bench and two others standing in the background, all wearing lab coats, gloves and sterile head covers. The person at the bench is holding a tube in the hand, visible on the bench is a stand with many tubes with black screw caps.

A new dawn in the fight against Tuberculosis

Today, UNITE4TB, an international public-private partnership striving to fast-track the development of innovative tuberculosis (TB) treatments, announced the start of its phase-IIb/c-clinical trial

DZIF Executive Board member Prof. Maura Dandri, DZIF managing director Dr Timo Jäger and ANRS | MIE Director Prof. Yazdan Yazdanpanah at the signing ceremony of the MoU at ANRS | MIE in Paris. Standing in the background are Roll-ups of ANRS | MIE and DZIF.

Collaboration of the DZIF and the French ANRS | MIE to advance research in infectious diseases

The German Center for Infection Research (DZIF) and the French National Research Agency for HIV, viral hepatitis and emerging infectious diseases (ANRS | MIE) announced their commitment to

A female doctor wearing a white coat injects the upper arm of an elderly man.

Protection against respiratory diseases: Medical associations recommend new RSV vaccination

New protection against severe respiratory diseases: Experts from eleven medical societies and institutions—including researchers from the German Center for Infection Research—are now calling on people

Cryo-electron microscopic reconstruction of molecular structures: On the left, the vertical representation of the binding of a yellow-coloured antibody to the blue-coloured tip of the secretion system shown in grey. On the right, a top view of the binding structure, showing how the yellow antibody binds laterally to the blue tip of the secretion system, which is round in top view.

Neutralising antibodies that target resistant bacteria

Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared

An Indian female lab technician holds the test cartridge tested in the study in her right hand.

New tool makes it easier to diagnose tuberculosis in children

Around 240,000 children worldwide die of tuberculosis every year. The disease is among the top ten causes of death in children under the age of five. One of the main reasons for this mortality is that

Whitish Acinetobacter baumannii colonies on a red agar plate

Avoiding the further spread of carbapenem-resistant Acinetobacter baumannii

Researchers from the German Center for Infection Research (DZIF) at the University of Cologne have conducted a study on the carbapenem-resistant bacterium Acinetobacter baumannii. The pathogen was

A photo of the podium - part of the audience can be seen from behind. Joël Denis stands at the lectern, the presentation slides are shown on a large screen.

How to create incentives for the development of novel antibiotics?

Every year at least 700,000 people die as a result of infection with antibiotic-resistant bacteria—a figure which according to WHO forecasts could rise to ten million people by 2050 without new